Skip to content

sandoz

Active
Public limited companyfounded 199630 yrs activeHermeslaan 1, 1831 Machelen (Brab.), BelgiumKBO/BCE: BE 0457.517.227
Summary

sandoz has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16.8m and a net result of €3.2m. Equity is growing by ~11% per year across the filed fiscal years. Its solvency ranks better than 33% of 5046 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability63▲+21
Solvency55▲+4
Growth65=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,050,000 at 30 days acceptable
Liquidity tight (current ratio 1.5 against 1.58 in 2024; short-term debt: 64.9% of total assets), and 69.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 30 years 0 40 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
30.3%
Return on assets
5.8%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
16 d early
2024
37 d early
2023
44 d early
2022
54 d early
2021
53 d early
2020
44 d early
2019
37 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 14 March 1996, sandoz was incorporated.1 In 2003 the company took the name SANDOZ.2 Since 2003 the registered office has moved 6 times, most recently to Diegem in 2025.23 Of the 2 current board members, Dries Pattyn has served longest, since 2023.4 Revenue went from EUR 100 million in 2018 to EUR 115 million in 2025 and headcount from 114 to 99.1 full-time equivalents.5

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 12-08-2003
  3. 3Belgian State Gazette, 11-03-2025
  4. 4Belgian State Gazette, 31-08-2023
  5. 5National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€115.3m▲ 3.0%
2024 · €111.9m
EBIT margin
4.2%▲ 2.2pp
2024 · 2.0%
Net result
€3.2m▲ 327%
2024 · €752,977
Working capital
€17.8m▼ 8.0%
2024 · €19.4m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€94.6m▼ 0.2%€97.2m▲ 2.7%€106.1m▲ 9.2%€111.9m▲ 5.5%€115.3m▲ 3.0%
Operating result€1.8m▲ 1.4%€2.0m▲ 14.5%€2.2m▲ 6.1%€2.2m▲ 4.0%€4.8m▲ 115%
Net result€876,805above the sector's middle half▼ 12.1%€1.5mabove the sector's middle half▲ 75.0%€1.2mabove the sector's middle half▼ 22.1%€752,977above the sector's middle half▼ 37.0%€3.2mabove the sector's middle half▲ 327%
EBIT margin1.9%=2.1%▲ 0.2pp2.0%▼ 0.1pp2.0%=4.2%▲ 2.2pp
Equity€10.1mabove the sector's middle half▲ 9.5%€11.6mabove the sector's middle half▲ 15.2%€12.8mabove the sector's middle half▲ 10.3%€13.6mabove the sector's middle half▲ 5.9%€16.8mabove the sector's middle half▲ 23.7%
Total assets€42.9mabove the sector's middle half▼ 20.1%€41.7mabove the sector's middle half▼ 2.8%€44.3mabove the sector's middle half▲ 6.1%€53.2mabove the sector's middle half▲ 20.3%€55.3mabove the sector's middle half▲ 4.0%
Debt€28.5m▼ 30.5%€26.3m▼ 7.8%€28.1m▲ 7.1%€33.3m▲ 18.5%€35.9m▲ 7.7%
Working capital€14.5mabove the sector's middle half▲ 15.8%€15.1mabove the sector's middle half▲ 3.7%€15.7mabove the sector's middle half▲ 4.1%€19.4mabove the sector's middle half▲ 23.6%€17.8mabove the sector's middle half▼ 8.0%
Solvency23.5%within the sector's middle half▲ 6.4pp27.9%within the sector's middle half▲ 4.4pp29.0%within the sector's middle half▲ 1.1pp25.5%within the sector's middle half▼ 3.5pp30.3%within the sector's middle half▲ 4.8pp
Current ratio1.52within the sector's middle half▲ 0.211.57within the sector's middle half▲ 0.061.56within the sector's middle half▼ 0.021.58within the sector's middle half▲ 0.021.50within the sector's middle half▼ 0.09
Return on assets (ROA)2.0%within the sector's middle half▲ 0.2pp3.7%within the sector's middle half▲ 1.6pp2.7%within the sector's middle half▼ 1.0pp1.4%within the sector's middle half▼ 1.3pp5.8%within the sector's middle half▲ 4.4pp
Staff (FTE)115.9above the sector's middle half▼ 5.8%109.2above the sector's middle half▼ 5.8%110.1above the sector's middle half▲ 0.8%103.7above the sector's middle half▼ 5.8%99.1above the sector's middle half▼ 4.4%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€2.0m€4.0mOperating result 2021: €1.8m€1.8mNet result 2021: €876,805€876,805Operating result 2022: €2.0m€2.0mNet result 2022: €1.5m€1.5mOperating result 2023: €2.2m€2.2mNet result 2023: €1.2m€1.2mOperating result 2024: €2.2m€2.2mNet result 2024: €752,977€752,977Operating result 2025: €4.8m€4.8mNet result 2025: €3.2m€3.2m20212022202320242025€0€2m€4mOperating result 2023: €2.2m€2.2mNet result 2023: €1.2m€1.2mOperating result 2024: €2.2m€2.2mNet result 2024: €752,977€753,000Operating result 2025: €4.8m€4.8mNet result 2025: €3.2m€3.2m202320242025
The operating result has risen four years in a row; 2025 is 115% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €55.3m
Fixed assets €1.6m ▲ 221%
Current assets €53.7m ▲ 1.9%
Equity and liabilities €55.3m
Equity €16.8m ▲ 23.7%
Provisions €2.6m ▼ 58.0%
Debt €35.9m ▲ 7.7%
Debt's share of the balance-sheet total rises from 62.6% to 64.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€4.9m▲
2024 · €2.3m
Cash flow
€3.3m▲
2024 · €802,779
Quick ratio
0.58▼
2024 · 0.64
Debt to equity
2.14▼
2024 · 2.46
ROE
19.1%▲
2024 · 5.5%
Interest coverage
9.85▲
2024 · 3.32
Debt ≤ 1 year
€35.9m▲
2024 · €33.3m
Income taxes
€1.1m▲
2024 · €786,706
Staff costs
€17.0m▲
2024 · €15.5m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,577 companies that looked in July 2024 the way this one looks now, 0.1% went bankrupt within 24 months and 97% are still going.

  • Medium-sized
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.1% went bankrupt
3.1% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,577 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 71 lines
Balance sheet Code20242025
Assets
Total assets20/58€53.2m€55.3m▲
Fixed assets21/28€502,249€1.6m▲
Tangible fixed assets22/27€36,091€1.1m▲
Plant, machinery and equipment23€4,330€94,868▲
Furniture and vehicles24€31,761€214,161▲
Other tangible fixed assets26-€799,955
Financial fixed assets28€466,158€505,228▲
Other financial fixed assets284/8€466,158€505,228▲
Amounts receivable and cash guarantees285/8€466,158€505,228▲
Current assets29/58€52.7m€53.7m▲
Stocks and contracts in progress3€31.4m€32.7m▲
Stocks30/36€31.4m€32.7m▲
Raw materials and consumables30/31€187,805€142,409▼
Finished goods33€102,387€29,278▼
Goods purchased for resale34€31.1m€32.6m▲
Amounts receivable within one year40/41€21.2m€21.0m▼
Trade receivables40€21.0m€20.9m▼
Other amounts receivable41€202,593€77,122▼
Deferred charges and accrued income490/1€115,005€50,870▼
Equity and liabilities
Total equity and liabilities10/49€53.2m€55.3m▲
Equity10/15€13.6m€16.8m▲
Contributions10/11€19.2m€19.2m=
Capital10€19.2m€19.2m=
Issued capital100€19.2m€19.2m=
Profit (loss) carried forward14-€5.7m-€2.5m▲
Provisions and deferred taxes16€6.3m€2.6m▼
Provisions for liabilities and charges160/5€6.3m€2.6m▼
Pensions and similar obligations160€1.6m€1.5m▼
Other liabilities and charges164/5€4.7m€1.1m▼
Amounts payable17/49€33.3m€35.9m▲
Amounts payable within one year42/48€33.3m€35.9m▲
Financial debts43€20.6m€18.4m▼
Other loans439€20.6m€18.4m▼
Trade debts44€7.7m€12.5m▲
Suppliers440/4€7.7m€12.5m▲
Taxes, remuneration and social security45€5.0m€5.0m▲
Taxes450/3€1.7m€2.0m▲
Remuneration and social security454/9€3.3m€3.0m▼
Other amounts payable47/48-€7,140
Income statement Code20242025
Operating income70/76A€122.1m€128.4m▲
Turnover70€111.9m€115.3m▲
Change in stocks of work in progress, finished goods and contracts in progress71€94,611-€73,109▼
Other operating income74€10.1m€9.8m▼
Non-recurring operating income76A-€3.3m
Operating charges60/66A€119.9m€123.6m▲
Goods for resale, raw materials and consumables60€79.2m€80.7m▲
Purchases600/8€82.8m€83.7m▲
Change in stocks: decrease (increase)609-€3.6m-€3.0m▲
Services and other goods61€11.8m€12.0m▲
Remuneration, social security and pensions62€15.5m€17.0m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€49,802€110,581▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€906,269€1.8m▲
Provisions for liabilities and charges: additions (uses and reversals)635/8-€237,801-€46,130▲
Other operating charges640/8€11.0m€11.9m▲
Non-recurring operating charges66A€3.5m-
Operating profit (loss)9901€2.2m€4.8m▲
Financial income75/76B€3€64▲
Recurring financial income75€3€64▲
Other financial income752/9€3€64▲
Financial charges65/66B€700,916€506,662▼
Recurring financial charges65€700,916€506,662▼
Debt charges650€690,045€499,463▼
Other financial charges652/9€10,871€7,199▼
Profit (loss) for the period before taxes9903€1.5m€4.3m▲
Income taxes67/77€786,706€1.1m▲
Taxes670/3€786,706€1.1m▲
Profit (loss) for the period9904€752,977€3.2m▲
Profit (loss) for the period to be appropriated9905€752,977€3.2m▲
Appropriation of the result
Profit (loss) to be appropriated9906-€5.7m-€2.5m▲
Profit (loss) brought forward from the previous period14P-€6.4m-€5.7m▲
Social balance
Average headcount (FTE)9087103.799.1▼

The notes to these accounts (52 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€107.9m€101.2m€113.5m€122.1m€128.4m▲ 5.1%
Turnover70€94.6m€97.2m€106.1m€111.9m€115.3m▲ 3.0%
Change in stocks of work in progress, finished goods and contracts in progress71€73,842-€115,212-€367,261€94,611-€73,109▼ 177%
Other operating income74€13.2m€4.2m€7.8m€10.1m€9.8m▼ 2.7%
Non-recurring operating income76A----€3.3m-
Operating charges60/66A€106.1m€99.2m€111.3m€119.9m€123.6m▲ 3.1%
Goods for resale, raw materials and consumables60€75.1m€67.7m€78.7m€79.2m€80.7m▲ 1.9%
Purchases600/8€61.5m€66.4m€80.3m€82.8m€83.7m▲ 1.1%
Change in stocks: decrease (increase)609€13.6m€1.3m-€1.6m-€3.6m-€3.0m▲ 17.2%
Services and other goods61€9.9m€10.2m€11.0m€11.8m€12.0m▲ 1.6%
Remuneration, social security and pensions62€15.0m€14.2m€14.3m€15.5m€17.0m▲ 9.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€774€774€62,845€49,802€110,581▲ 122%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€1.6m€400,157-€1.1m-€906,269€1.8m▲ 295%
Provisions for liabilities and charges: additions (uses and reversals)635/8€847,153-€526,900-€550,331-€237,801-€46,130▲ 80.6%
Other operating charges640/8€6.9m€7.1m€8.8m€11.0m€11.9m▲ 8.9%
Non-recurring operating charges66A€479€26,451€1,069€3.5m--
Operating profit (loss)9901€1.8m€2.0m€2.2m€2.2m€4.8m▲ 115%
Financial income75/76B€3,341€411€5,148€3€64▲ 1,749%
Recurring financial income75€3,341€411€5,148€3€64▲ 1,749%
Other financial income752/9€3,341€411€5,148€3€64▲ 1,749%
Financial charges65/66B€74,252€89,894€497,381€700,916€506,662▼ 27.7%
Recurring financial charges65€74,252€89,894€497,381€700,916€506,662▼ 27.7%
Debt charges650€71,402€80,703€494,948€690,045€499,463▼ 27.6%
Other financial charges652/9€2,850€9,191€2,433€10,871€7,199▼ 33.8%
Profit (loss) for the period before taxes9903€1.7m€1.9m€1.7m€1.5m€4.3m▲ 179%
Income taxes67/77€826,130€406,999€466,797€786,706€1.1m▲ 38.4%
Taxes670/3€826,130€406,999€505,062€786,706€1.1m▲ 38.4%
Tax adjustments and reversals of tax provisions77--€38,265---
Profit (loss) for the period9904€876,805€1.5m€1.2m€752,977€3.2m▲ 327%
Profit (loss) for the period to be appropriated9905€876,805€1.5m€1.2m€752,977€3.2m▲ 327%
Line20212022202320242025Change
Assets
Total assets20/58€42.9m€41.7m€44.3m€53.2m€55.3m▲ 4.0%
Fixed assets21/28€212,136€360,142€491,261€502,249€1.6m▲ 221%
Tangible fixed assets22/27€1,548€774€85,893€36,091€1.1m▲ 2,973%
Plant, machinery and equipment23€1,548€774€39,458€4,330€94,868▲ 2,091%
Furniture and vehicles24-€0€46,435€31,761€214,161▲ 574%
Other tangible fixed assets26----€799,955-
Financial fixed assets28€210,588€359,368€405,368€466,158€505,228▲ 8.4%
Other financial fixed assets284/8€210,588€359,368€405,368€466,158€505,228▲ 8.4%
Amounts receivable and cash guarantees285/8€210,588€359,368€405,368€466,158€505,228▲ 8.4%
Current assets29/58€42.7m€41.3m€43.8m€52.7m€53.7m▲ 1.9%
Stocks and contracts in progress3€26.3m€24.4m€26.7m€31.4m€32.7m▲ 4.3%
Stocks30/36€26.3m€24.4m€26.7m€31.4m€32.7m▲ 4.3%
Raw materials and consumables30/31€128,943€222,933€235,420€187,805€142,409▼ 24.2%
Finished goods33€490,249€375,037€7,776€102,387€29,278▼ 71.4%
Goods purchased for resale34€25.7m€23.8m€26.5m€31.1m€32.6m▲ 4.8%
Amounts receivable within one year40/41€16.1m€16.9m€17.0m€21.2m€21.0m▼ 1.3%
Trade receivables40€15.9m€16.1m€16.7m€21.0m€20.9m▼ 0.7%
Other amounts receivable41€170,557€813,405€320,268€202,593€77,122▼ 61.9%
Deferred charges and accrued income490/1€354,992€4,400€30,381€115,005€50,870▼ 55.8%
Equity and liabilities
Total equity and liabilities10/49€42.9m€41.7m€44.3m€53.2m€55.3m▲ 4.0%
Equity10/15€10.1m€11.6m€12.8m€13.6m€16.8m▲ 23.7%
Contributions10/11€19.2m€19.2m€19.2m€19.2m€19.2m=
Capital10€19.2m€19.2m€19.2m€19.2m€19.2m=
Issued capital100€19.2m€19.2m€19.2m€19.2m€19.2m=
Profit (loss) carried forward14-€9.1m-€7.6m-€6.4m-€5.7m-€2.5m▲ 56.7%
Provisions and deferred taxes16€4.3m€3.8m€3.3m€6.3m€2.6m▼ 58.0%
Provisions for liabilities and charges160/5€4.3m€3.8m€3.3m€6.3m€2.6m▼ 58.0%
Pensions and similar obligations160€2.9m€2.4m€1.8m€1.6m€1.5m▼ 2.9%
Other liabilities and charges164/5€1.4m€1.4m€1.5m€4.7m€1.1m▼ 76.7%
Amounts payable17/49€28.5m€26.3m€28.1m€33.3m€35.9m▲ 7.7%
Amounts payable within one year42/48€28.2m€26.3m€28.1m€33.3m€35.9m▲ 7.7%
Financial debts43€14.3m€11.3m€14.4m€20.6m€18.4m▼ 10.9%
Other loans439€14.3m€11.3m€14.4m€20.6m€18.4m▼ 10.9%
Trade debts44€10.0m€10.9m€8.9m€7.7m€12.5m▲ 62.2%
Suppliers440/4€10.0m€10.9m€8.9m€7.7m€12.5m▲ 62.2%
Taxes, remuneration and social security45€3.8m€4.1m€4.7m€5.0m€5.0m▲ 0.5%
Taxes450/3€712,543€580,049€1.2m€1.7m€2.0m▲ 22.9%
Remuneration and social security454/9€3.1m€3.5m€3.5m€3.3m€3.0m▼ 10.7%
Other amounts payable47/48€2,490€2,998€4,370-€7,140-
Accrued charges and deferred income492/3€318,789€0€48,821---
Line20212022202320242025Change
Profit (loss) for the period9904€876,805€1.5m€1.2m€752,977€3.2m▲ 327%
+ Depreciation and write-downs630€774€774€62,845€49,802€110,581▲ 122%
Operating cash flow (approximation)€877,579€1.5m€1.3m€802,779€3.3m▲ 314%
Investment in fixed assets (approximation)--€148,780-€193,964-€60,790-€1.2m▼ 1,911%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
15-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
26-02
State Gazette act Resignation: Rodrigo Osorio Aguilar (director)
Appointment: Ankit Agarwal (director) · Power of attorney5 facts ▸
  • General meeting, 11 februari 2026
  • Director resignation, Rodrigo Osorio Aguilar (director)
  • Director appointment, Ankit Agarwal (director)
  • Board meeting, 11 februari 2026
  • Power of attorney, Ankit Agarwal
2025
31-12
Financial Highest result since 2018net €3.2m ▲327%
Operating result €4.8m, net result €3.2m, both a record.
18-07
State Gazette act Appointment: KPMG Bedrijfsrevisoren (statutory auditor)
Resignation: Anatoliy Ivanov (director) · Power of attorney12 facts ▸
  • General meeting, 03/06/2025
  • General meeting, 08/07/2025
  • Board meeting, 07/2025
  • Auditor appointment, KPMG Bedrijfsrevisoren (statutory auditor)
  • Director resignation, Anatoliy Ivanov (director)
  • Power of attorney, Quinz BV
  • Power of attorney, Ad-ministerie BV
  • Power of attorney, Quinz BV
  • Power of attorney, Ad-ministerie BV
  • Power of attorney, Anatoliy Ivanov
  • Power of attorney, Quinz BV
  • Power of attorney, Ad-ministerie BV
24-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
11-03
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 27/02/2025
  • Registered-office move, Hermeslaan 1, gebouw H, 4de verdiep, 1831 Diegem, België
28-02
State Gazette act Resignation: Christophe Delenta (director)
Appointment: Rodrigo Osorio Aguilar (director) · Ratification5 facts ▸
  • General meeting, 08/01/2025
  • Board meeting, 03/02/2025
  • Director resignation, Christophe Delenta (director)
  • Director appointment, Rodrigo Osorio Aguilar (director)
  • Ratification, ratification of actions as external representative for public contracts/tenders and legal proceedings up to 1M EUR between 01/05/2024 and 03/02/2025
28-02
State Gazette act Resignations & appointments
Power of attorney6 facts ▸
  • Board meeting, 03/02/2025
  • Power of attorney, Dries Pattyn
  • Power of attorney, Anatoliy Ivanov
  • Power of attorney, Dries Pattyn
  • Power of attorney, Anatoliy Ivanov
  • Power of attorney, Maria Jose Gomez Silva
2024
25-11
State Gazette act Miscellaneous
Registered-office move2 facts ▸
  • Board meeting, 21/10/2024
  • Registered-office move, Centralbahnstrasse 4, 4051 Basel, Zwitserland
17-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-08
State Gazette act Resignations: Federico Mambretti (director) and Andrea Majocchi (director)
Appointments: Dries Pattyn (director) and Christophe Delenta (director) · Power of attorney · Ratification12 facts ▸
  • General meeting, 29-06-2023
  • Director resignation, Federico Mambretti (director)
  • Director resignation, Andrea Majocchi (director)
  • Director appointment, Dries Pattyn (director)
  • Director appointment, Christophe Delenta (director)
  • Board meeting, 05-07-2023
  • Director appointment, Dries Pattyn (chair)
  • Power of attorney, Dries Pattyn
  • Power of attorney, Anatoliy Ivanov
  • Power of attorney, Anatoliy Ivanov
  • Director resignation, Federico Mambretti (chair)
  • Ratification, aanvaarden en uitdrukkelijk bekrachtigen van handelingen gesteld onder volmacht van 30 juni 2021
07-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
Show earlier events
24-03
State Gazette act Capital & shares
Share transfer3 facts ▸
  • Board meeting, 09/03/2023
  • Share transfer, Novartis Pharma NV → Sandoz AG
  • Share transfer, Novartis Pharma AG → Sandoz AG
08-02
State Gazette act Resignation: Bruno De Ultra De Sousa Barcelos (director)
Appointment: Anatoliy Ivanov (director) · Power of attorney6 facts ▸
  • General meeting, 16/01/2023
  • Board meeting, 16/01/2023
  • Director resignation, Bruno De Ultra De Sousa Barcelos (director)
  • Director appointment, Anatoliy Ivanov (director)
  • Director resignation, Bruno De Ultra De Sousa Barcelos (day-to-day manager)
  • Power of attorney, Bruno De Ultra De Sousa Barcelos
2022
12-08
State Gazette act Resignations & appointments
Power of attorney3 facts ▸
  • Board meeting, 18/07/2022
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Maria Jose Gomez
24-06
State Gazette act Appointments: PRICEWATERHOUSE COOPERS BEDRIJFSREVISOREN BV (statutory auditor) and KPMG Bedrijfsrevisoren BV (statutory auditor)
Permanent representatives: Cleenewerck Ann and Steven Veyt5 facts ▸
  • General meeting, 07/06/2022
  • Auditor appointment, PRICEWATERHOUSE COOPERS BEDRIJFSREVISOREN BV (statutory auditor)
  • Auditor appointment, KPMG Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Cleenewerck Ann
  • Permanent representative, Steven Veyt
08-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
21-04
State Gazette act Resignations: Guy Oliver (director) and Nicolas Thiriet (director)
Appointments: Federico Mambretti (director) and Andrea Majocchi (director)5 facts ▸
  • General meeting, 30-03-2022
  • Director resignation, Guy Oliver (director)
  • Director resignation, Nicolas Thiriet (director)
  • Director appointment, Federico Mambretti (director)
  • Director appointment, Andrea Majocchi (director)
2021
31-12
Financial Equity above €10mEq €10.1m ▲9.5%
4 profitable years in a row build equity to €10.1m.
04-10
State Gazette act Resignation: Andrej Pardo (director)
Appointment: Guy Oliver (director)4 facts ▸
  • General meeting, 20/09/2021
  • Director resignation, Andrej Pardo (director)
  • Director appointment, Guy Oliver (director)
  • Director appointment, Guy Oliver (chair)
05-08
State Gazette act Resignations & appointments
Power of attorney6 facts ▸
  • Board meeting, 30/06/2021
  • Power of attorney, Ezgi Tasdemir
  • Power of attorney, Quinz Advooaten
  • Power of attorney, Bruno Barcelos
  • Power of attorney, Anatoliy Ivanov
  • Power of attorney, Johan Deberlanger
17-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
27-05
State Gazette act Resignations & appointments
Power of attorney4 facts ▸
  • Board meeting, 05/05/2021
  • Power of attorney, Bruno Barcelos
  • Power of attorney, Ezgi Tasdemir
  • Power of attorney, Johan Deberlanger
17-02
State Gazette act Resignations & appointments
Power of attorney5 facts ▸
  • Board meeting, 14/01/2021
  • Power of attorney, Jens Thiede
  • Power of attorney, Bruno Barcelos
  • Power of attorney, Ezgi Tasdemir
  • Power of attorney, Johan Deberlanger
28-01
State Gazette act Purpose · Statutes amendment
Purpose change · Power of attorney3 facts ▸
  • General meeting, 19/01/2021
  • Purpose change, De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, het raadgeven, de studie en de organisatie van alle handelsstoffen, daarin begrepen d…
  • Power of attorney, Cody Demuytere
2020
09-07
State Gazette act Appointment: PwC Bedijfsrevisoren CVBA (statutory auditor)
2 facts ▸
  • General meeting, 24/06/2020
  • Auditor appointment, PwC Bedijfsrevisoren CVBA (statutory auditor)
24-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
03-06
State Gazette act Statutes amendment
Capital3 facts ▸
  • General meeting, 27/05/2020
  • Statutes amendment
  • Capital, €19.240.000
20-02
State Gazette act Resignations & appointments
Power of attorney4 facts ▸
  • Board meeting, 29/01/2020
  • Power of attorney, Diedert Geysen
  • Power of attorney, Bruno Barcelos
  • Power of attorney, Jens Thiede
2019
14-11
State Gazette act Resignations: Knut Magerl (director) and Rebecca Guntern Flückiger (director)
Appointments: Bruno Barcelos (director) and Andrej Pardo (director)5 facts ▸
  • General meeting, 13-09-2019
  • Director resignation, Knut Magerl (director)
  • Director resignation, Rebecca Guntern Flückiger (director)
  • Director appointment, Bruno Barcelos (director)
  • Director appointment, Andrej Pardo (director)
13-11
State Gazette act Permanent representative: Ann Cleenewerck
Power of attorney · Approval4 facts ▸
  • Board meeting, 30/10/2019
  • Permanent representative, Ann Cleenewerck
  • Power of attorney, Diedert Geysen
  • Approval, 30/10/2019
09-07
State Gazette act Resignation: Dario Drago (director)
Appointment: Nicolas Thiriet (director)4 facts ▸
  • General meeting, 04/06/2019
  • Director resignation, Dario Drago (director)
  • Director appointment, Nicolas Thiriet (director)
  • Director appointment, Nicolas Thiriet (secretaris van de raad van bestuur)
07-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
11-12
State Gazette act Resignation: Inge De Vuyst (head business unit retail & specialty)
Appointment: Marco Pucci (head business unit retail & specialty) · Power of attorney14 facts ▸
  • Board meeting, 03/10/2018
  • Director resignation, Inge De Vuyst (head business unit retail & specialty)
  • Director appointment, Marco Pucci (head business unit retail & specialty)
  • Power of attorney, Bruno de Ultra de Sousa Barcelos
  • Power of attorney, Jens-Peter Thiede
  • Power of attorney, Marco Pucci
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Bjoern Van Den Sande
  • Power of attorney, Martine Uytdenhoef
  • Power of attorney, Isabelle Dupuis
  • Power of attorney, Diedert Geysen
  • Power of attorney, Aude Vileyn
  • +2 further facts in this act
12-10
State Gazette act Appointments: Diedert Geysen, Aude Vileyn and Nicolas Steylemans
Power of attorney · Representation threshold · Ratification20 facts ▸
  • Board meeting, 14 september 2018
  • Director appointment, Diedert Geysen (business unit head hospital)
  • Director appointment, Aude Vileyn (head human resources)
  • Director appointment, Nicolas Steylemans (head strategic planning)
  • Power of attorney, Bruno de Ultra de Sousa Barcelos
  • Power of attorney, Jens-Peter Thiede
  • Power of attorney, Inge De Vuyst
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Bjoern Van Den Sande
  • Power of attorney, Martine Uytdenhoef
  • Power of attorney, Isabelle Dupuis
  • Power of attorney, Aude Vileyn
  • +8 further facts in this act
27-06
State Gazette act Resignations: Rebecca Guntern (afgevaardigde bestuurder) and Dirk Grauwels (head business hospital)
Appointments: Bruno de Ultra de Sousa Barcelos (general manager belast met het dagelijks bestuur) and Jens-Peter Thiede (chief finance officer) · Power of attorney17 facts ▸
  • Board meeting, 21/03/2018
  • Director resignation, Rebecca Guntern (afgevaardigde bestuurder)
  • Power of attorney, Johan Deberlanger
  • Director resignation, Dirk Grauwels (head business hospital)
  • Power of attorney, Dirk Grauwels
  • Director appointment, Bruno de Ultra de Sousa Barcelos (general manager belast met het dagelijks bestuur)
  • Director appointment, Jens-Peter Thiede (chief finance officer)
  • Power of attorney, Bruno de Ultra de Sousa Barcelos
  • Power of attorney, Jens-Peter Thiede
  • Power of attorney, Bruno de Ultra de Sousa Barcelos
  • Power of attorney, Jens-Peter Thiede
  • Power of attorney, Inge De Vuyst
  • +5 further facts in this act
12-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
07-06
State Gazette act Appointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Romain Seffer · Mandate term4 facts ▸
  • General meeting, 13/07/2017
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Romain Seffer
  • Mandate term, na de algemene vergadering der aandeelhouders die de jaarrekening per 31 december 2019 dient goed te keuren
16-04
State Gazette act Appointment: Johan Deberlanger (afgevaardigd bestuurder)
Power of attorney9 facts ▸
  • Board meeting, 07/12/2017
  • Director appointment, Johan Deberlanger (afgevaardigd bestuurder)
  • Power of attorney, Rebecca Guntern
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Inge De Vuyst
  • Power of attorney, Dirk Grauwels
  • Power of attorney, Martine Uytdenhoef
  • Power of attorney, Bjoern Van Den Sande
  • Power of attorney, Isabelle Dupuis
03-01
State Gazette act Resignation: Vincent Verschraegen (general manager)
Appointment: Rebecca Guntern (general manager belast met het dagelijks bestuur) · Power of attorney6 facts ▸
  • Board meeting, 02/10/2017
  • Director resignation, Vincent Verschraegen (general manager)
  • Power of attorney, Vincent Verschraegen
  • Director appointment, Rebecca Guntern (general manager belast met het dagelijks bestuur)
  • Power of attorney, Rebecca Guntern
  • Power of attorney, Allen & Overy (Belgium) LLP
2017
07-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
02-08
State Gazette act Appointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Romain Seffer3 facts ▸
  • General meeting, 08/07/2016
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Romain Seffer (representative)
26-05
State Gazette act Resignations: Sue Webb (director) and Nicholas Haggar (director)
Appointments: Knut Mager, Rebecca Guntern and Nancy Vander Linden6 facts ▸
  • General meeting, 08/01/2016
  • Director resignation, Sue Webb (director)
  • Director resignation, Nicholas Haggar (director)
  • Director appointment, Knut Mager (director)
  • Director appointment, Rebecca Guntern (director)
  • Director appointment, Nancy Vander Linden (chair)
26-05
State Gazette act Appointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: BVBA Romain Seffer3 facts ▸
  • General meeting, 02/06/2015
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, BVBA Romain Seffer (representative)
2015
15-01
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 24/10/2014
  • Registered-office move, Medialaan 40 te 1800 Vilvoorde
2013
12-11
State Gazette act Resignations & appointments
Power of attorney6 facts ▸
  • Board meeting, 14-10-2013
  • Power of attorney, Dirk Grauwels
  • Power of attorney, Vincent Verschraegen
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Dirk Grauwels
  • Power of attorney, Romain Lege
19-09
State Gazette act Resignation: Dominique Petit (general manager)
Appointment: Vincent Verschraegen (general manager) · Power of attorney7 facts ▸
  • Board meeting, 26/07/2013
  • Director resignation, Dominique Petit (general manager)
  • Director appointment, Vincent Verschraegen (general manager)
  • Power of attorney, Dominique Petit
  • Power of attorney, Vincent Verschraegen
  • Power of attorney, Johan Deberlanger
  • Power of attorney, Romain Légé
21-05
State Gazette act Registered office · Other addresses
Registered-office move2 facts ▸
  • Board meeting, 24/05/2012
  • Registered-office move, Lichterveld 7 te 2870 Puurs
31-01
State Gazette act Resignation: Dubos (director)
Appointment: Sue Webb (director)3 facts ▸
  • Board meeting, 06/12/2012
  • Director resignation, Dubos (director)
  • Director appointment, Sue Webb (director)
2012
27-07
State Gazette act Appointments: Romain Légé, Jean-Claude Dubos and Nicholas Haggar
Resignation: F.R. Simoes (director)6 facts ▸
  • General meeting, 05/06/2012
  • Director appointment, Romain Légé (director)
  • Director appointment, Romain Légé (chair)
  • Director resignation, F.R. Simoes (director)
  • Director appointment, Jean-Claude Dubos (director)
  • Director appointment, Nicholas Haggar (director)
20-07
State Gazette act Appointments: Romain Légé, Jean-Claude Dubos and Nicholas Haggar
Resignation: F.R. Simoes (director)6 facts ▸
  • General meeting, 5 juni 2012
  • Director appointment, Romain Légé (director)
  • Director appointment, Romain Légé (chair)
  • Director resignation, F.R. Simoes (director)
  • Director appointment, Jean-Claude Dubos (director)
  • Director appointment, Nicholas Haggar (director)
28-02
State Gazette act Resignation: Frederic Rodrigues Simoes (director)
Appointment: Romain Légé (director)3 facts ▸
  • Board meeting, 12/10/2011
  • Director resignation, Frederic Rodrigues Simoes (director)
  • Director appointment, Romain Légé (director)
2011
30-09
State Gazette act Reappointment: Frederic Rodrigues Simoes (director)
Appointments: Frederic Rodrigues Simoes (chair) and BCVBA PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor) · Permanent representative: Romain Seffer · Mandate compensation8 facts ▸
  • General meeting, 07-06-2011
  • Director reappointment, Frederic Rodrigues Simoes (director)
  • Director appointment, Frederic Rodrigues Simoes (chair)
  • Mandate compensation, Frederic Rodrigues Simoes
  • Mandate compensation, Jean-Claude Dubos
  • Mandate compensation, Nicholas Haggar
  • Auditor appointment, BCVBA PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Romain Seffer
2010
16-12
State Gazette act Registered office · Other addresses
Registered-office move2 facts ▸
  • Board meeting, 22/11/2010
  • Registered-office move, Wayenborgstraat 22 te 2800 Mechelen
2008
08-08
State Gazette act Appointments: Frederic R. Simoes (director) and PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
Permanent representative: Raynald Vermoesen · Mandate compensation5 facts ▸
  • General meeting, 03/06/2008
  • Director appointment, Frederic R. Simoes (director)
  • Mandate compensation, Sandoz
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Raynald Vermoesen
31-03
State Gazette act Resignation: Bertrand Bugnon (director)
Appointment: Frederic Rodrigues Simoes (director) · Mandate compensation5 facts ▸
  • Board meeting, 14/11/2007
  • Director resignation, Bertrand Bugnon (director)
  • Director appointment, Frederic Rodrigues Simoes (director)
  • Director appointment, Frederic Rodrigues Simoes (chair of the board)
  • Mandate compensation, Sandoz
2006
02-01
State Gazette act Resignations: Siegfried Leitner (director) and Eric Gorka (algemeen directeur)
Appointments: Andreas Strüngmann (director) and Dominique Petit (algemeen directeur) · Mandate compensation6 facts ▸
  • Board meeting, 30 september 2005
  • Director resignation, Siegfried Leitner (director)
  • Director appointment, Andreas Strüngmann (director)
  • Director resignation, Eric Gorka (algemeen directeur)
  • Director appointment, Dominique Petit (algemeen directeur)
  • Mandate compensation, Sandoz
2005
25-07
State Gazette act Appointment: PricewaterhouseCoopers scc (statutory auditor)
Permanent representative: Raynald Vermoesen3 facts ▸
  • General meeting, 07/06/2005
  • Auditor appointment, PricewaterhouseCoopers scc (statutory auditor)
  • Permanent representative, Raynald Vermoesen
2003
12-08
State Gazette act Capital & shares · Statutes amendment · Resignations & appointments
Name change · Registered-office move · Power of attorney6 facts ▸
  • General meeting, 16/07/2003
  • Name change, SANDOZ
  • Statutes amendment
  • Statutes amendment
  • Registered-office move, 1800 Vilvoorde, Medialaan, 40
  • Power of attorney, de raad van bestuur
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.
48 of 48 acts read

Directors · office · real estate

Directors
2 directors, no change since 2026

Board 2

Dries Pattyn
Chair · since 29-06-2023 · Director · since 29-06-2023
Current
Ankit Agarwal
Director · since 11-02-2026
Current
7 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Romain Légé
Chair · since 05-06-2012 · Director · since 12-10-2011
Not recently confirmed
Andreas Strüngmann
Director · since 30-09-2005
Not recently confirmed
Frederic R. Simoes
Director · since 03-06-2008
Not recently confirmed
Jean-Claude Dubos
Director · since 05-06-2012
Not recently confirmed
Knut Mager
Director · since 08-01-2016
Not recently confirmed
Bruno Barcelos
Director · since 13-09-2019
Not recently confirmed
Not recently confirmed

Day-to-day management 1

Johan Deberlanger
Afgevaardigd bestuurder · since 07-12-2017
Not recently confirmed

Statutory auditor 1

KPMG Bedrijfsrevisoren
Statutory auditor · since 24-06-2022 · perm. rep.: Steven Veyt
Current

Other functions 5

Jens-Peter Thiede
Chief finance officer · since 01-02-2018
Not recently confirmed
Diedert Geysen
Business unit head hospital · since 01-05-2018
Not recently confirmed
Aude Vileyn
Head human resources · since 07-05-2018
Not recently confirmed
Nicolas Steylemans
Head strategic planning · since 25-06-2018
Not recently confirmed
Marco Pucci
Head business unit retail & specialty · since 01-10-2018
Not recently confirmed
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Machelen (Brab.) · 1 establishment unit since 1996
seat establishment The establishment unit on the map
Ground area
1.4 ha
Building footprint
6,011 m²
Volume, LiDAR
66,740 m³
Parcel 23015B0102/00F000, Flanders · tallest building 28.4 m, ±5 floors. Linked by address, not a title deed.
14 companies at this address See who is registered here
1 establishment unit
NOVARTIS
Hermeslaan 1, 1831 Machelen (Brab.)Air transport
since 19962.076.166.224
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23015B0102/00F000 Flanders 1.4 ha 1 · 6,011 m² 28.4 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

43 people since 2005, 16 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • Other function
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Dries Pattyn
  • Chair, from 29-06-2023 to date
  • Director, from 29-06-2023 to date
Ankit Agarwal
  • Director, from 11-02-2026 to date
KPMG Bedrijfsrevisoren
  • Statutory auditor, from 24-06-2022 to date
Andreas Strüngmann
  • Director, from 30-09-2005 not ended, last confirmed 02-01-2006
Frederic R. Simoes
  • Director, from 03-06-2008 not ended, last confirmed 08-08-2008
Romain Légé
  • Director, from 12-10-2011 not ended, last confirmed 27-07-2012
  • Chair, from 05-06-2012 not ended, last confirmed 27-07-2012
Jean-Claude Dubos
  • Director, from 05-06-2012 not ended, last confirmed 27-07-2012
Knut Mager
  • Director, from 08-01-2016 not ended, last confirmed 26-05-2016
Knut Mager Webb
  • Director, already before 02-08-2016 not ended, last confirmed 02-08-2016
Bruno Barcelos
  • Director, from 13-09-2019 not ended, last confirmed 14-11-2019
Johan Deberlanger
  • Afgevaardigd bestuurder, from 07-12-2017 not ended, last confirmed 16-04-2018
Jens-Peter Thiede
  • Chief finance officer, from 01-02-2018 not ended, last confirmed 27-06-2018
Diedert Geysen
  • Business unit head hospital, from 01-05-2018 not ended, last confirmed 12-10-2018
Aude Vileyn
  • Head human resources, from 07-05-2018 not ended, last confirmed 12-10-2018
Nicolas Steylemans
  • Head strategic planning, from 25-06-2018 not ended, last confirmed 12-10-2018
Marco Pucci
  • Head business unit retail & specialty, from 01-10-2018 not ended, last confirmed 11-12-2018
Rodrigo Osorio Aguilar
  • Director, from 08-01-2025 to 01-02-2026
Anatoliy Ivanov
  • Director, from 31-12-2022 to 06-06-2025
Christophe Delenta
  • Director, from 29-06-2023 to 08-01-2025
Andrea Majocchi
  • Director, from 01-02-2022 to 29-06-2023
Federico Mambretti
  • Director, from 01-02-2022 to 29-06-2023
  • Chair, until 29-06-2023
Bruno De Ultra De Sousa Barcelos
  • General manager belast met het dagelijks bestuur, from 01-04-2018 to 31-12-2022
  • Director, until 31-12-2022
Pricewaterhouse Coopers Bedrijfsrevisoren BV
  • Statutory auditor, from 25-07-2005 to 24-06-2022
Guy Oliver
  • Director, from 20-09-2021 to 01-02-2022
  • Chair, from 04-10-2021 ended, last mentioned 04-10-2021
Nicolas Thiriet
  • Director, from 04-06-2019 to 01-02-2022
  • Secretaris van de raad van bestuur, from 04-06-2019 ended, last mentioned 09-07-2019
Andrej Pardo
  • Director, from 13-09-2019 to 20-09-2021
Knut Magerl
  • Director, until 13-09-2019
Rebecca Guntern Flückiger
  • Director, until 13-09-2019
Dario Drago
  • Chair of the board, from 07-06-2016 ended, last mentioned 02-08-2016
  • Director, from 07-06-2016 to 04-06-2019
Inge De Vuyst
  • Head business unit retail & specialty, until 01-10-2018
Dirk Grauwels
  • Head business hospital, until 30-04-2018
Rebecca Guntern
  • Director, from 08-01-2016 ended, last mentioned 02-08-2016
  • General manager belast met het dagelijks bestuur, from 02-10-2017 to 01-04-2018
Vincent Verschraegen
  • General manager, from 15-07-2013 to 02-10-2017
Nancy Vander Linden
  • Chair, from 26-05-2016 ended, last mentioned 26-05-2016
  • Director, until 02-08-2016
Nicholas Haggar
  • Director, from 05-06-2012 to 26-05-2016
Sue Webb
  • Director, from 06-12-2012 to 26-05-2016
Dominique Petit
  • Algemeen directeur, from 01-10-2005 ended, last mentioned 02-01-2006
  • General manager, until 15-07-2013
Dubos
  • Director, until 06-12-2012
F.R. Simoes
  • Director, until 05-06-2012
  • Director, until 27-07-2012
Frederic Rodrigues Simoes
  • Chair of the board, from 14-11-2007 ended, last mentioned 30-09-2011
  • Director, from 14-11-2007 to 21-06-2011
Bertrand Bugnon
  • Director, until 01-11-2007
Siegfried Leitner
  • Director, until 13-07-2005
Eric Gorka
  • Algemeen directeur, until 01-05-2005
See the board, name and seat on a given date →

Articles of association

Purpose
De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, het raadgeven, de studie en de organisatie van alle handelsstoffen, daarin begrepen de aankoop, verkoop…
Full purpose

De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, het raadgeven, de studie en de organisatie van alle handelsstoffen, daarin begrepen de aankoop, verkoop, fabricatie, de vertegenwoordiging, de invoering, de uitvoering, het agentschap, de makelarij, de commissie, de consignatie van alle goederen. De vennootschap kan alle roerende of onroerende goederen, uitbatings- of voorzieningsgoederen verwerven, verhuren of huren, oprichten, vervreemden of ruilen, en, in het algemeen, alle hoegenaamde handels-, industriële, financiële, roerende of onroerende verrichtingen uitvoeren, die rechtstreeks of onrechtstreeks in verband staan met haar voorwerp, daarin begrepen de onderaanneming in het algemeen en de uitbating van alle intellectuele rechten en industriële of handelseigendomsrecht dienaangaande; zij kan alle roerende of onroerende goederen ten titel van belegging verwerven, zelfs deze die niet rechtstreeks of onrechtstreeks in verband staan met haar voorwerp. De vennootschap mag voorzien in het bestuur, het oppertoezicht en de controle van alle verbonden vennootschappen of waarmee een participatieband en alle anderen, alle leningen toestaan, in enigerlei vormen of voor enigerlei duur. Ze mag door middel van inbreng in speciën of in natura, fusie, inschrijving, participatie, financiële tussenkomst of op andere vorm deelnemen in alle bestaande of te creëren zaken of onderneming in België of in het buiteland met een identiek, gelijkaardig, verwant of aanvullend voorwerp of die de verwezenlijking van haar voorwerp kunnen bevorderen. Huidige lijst is aanduidend en niet limitatief.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. Sandoz AGCH 100%
  2. sandoz

Highest known parent: Sandoz AG (Switzerland). The sources do not say who stands above it.

Owners 1

Holdings 0

The accounts to 31-12-2025 list no holdings, and no other source names one.

According to the 2025 annual accounts of sandoz and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

2 connected companies
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors

Capital and shareholders

Shareholders according to the acts
Share transfer act of 24-03-2023 ↗
  • Novartis Pharma NV to Sandoz AG
  • Novartis Pharma AG to Sandoz AG

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 03-06-2020 Capital stated in the act · 19,240,000 EUR · 776,129 shares

Public money · subsidies and aid

Flemish government

2022 to 2025 · 5 entries · 10,729 EUR awarded · 10,729 EUR paid
Year Entries awardedpaid
2025 2 -1,935 EUR997 EUR
2024 1 9,000 EUR6,068 EUR
2023 1 2,556 EUR2,556 EUR
2022 1 1,108 EUR1,108 EUR
Schemes
2 entries · 6,068 EUR · 6,068 EUR paid · Departement Werk en Sociale Economie
3 entries · 4,661 EUR · 4,661 EUR paid · Departement Werk en Sociale Economie

Recognitions · licences · registrations

Legal Entity Identifier

5493008UVF6UC0ZX0Y37
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 361 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded14-03-1996
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
Contact
Website www.sandoz.beMachelen (Brab.)
Phone 0032 2 722 97 97Machelen (Brab.)
Fax 0032 2 722 97 90Machelen (Brab.)
E-invoicing
Reachable via Peppol
Peppol ID 0208:0457517227
Also 9925:BE0457517227
Registered 11-12-2025

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.